tm logo
MENBESRY
Live/Pending
PUBLISHED FOR OPPOSITION

on 02 Apr 2024

Last Applicant/ Owned by

Rue de l'Institut 89

Rixensart

BE

B-1330

Serial Number

97251126 filed on 02th Feb 2022

Registration Number

N/A

Correspondent Address

Christopher M. Hanes

GSK

410 Blackwell Street

Legal Brand Protection

Durham, NC 27701

Filing Basis

No Filing Basis

Disclaimer

NO DATA

MENBESRY

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseaseRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Mark Details


Serial Number

No 97251126

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84146589

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Apr 2024PUBLISHED FOR OPPOSITION
02th Apr 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13th Mar 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27th Feb 2024APPROVED FOR PUB - PRINCIPAL REGISTER
07th Feb 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07th Feb 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
07th Feb 2024TEAS/EMAIL CORRESPONDENCE ENTERED
06th Feb 2024ASSIGNED TO LIE
15th Sep 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30th Aug 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED